These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 18848857)

  • 1. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge.
    Saxena S; Dahiya SS; Sonwane AA; Patel CL; Saini M; Rai A; Gupta PK
    Vaccine; 2008 Dec; 26(51):6592-601. PubMed ID: 18848857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein.
    Saxena S; Sonwane AA; Dahiya SS; Patel CL; Saini M; Rai A; Gupta PK
    Vet Microbiol; 2009 Apr; 136(1-2):36-44. PubMed ID: 19081687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
    Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M
    Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing comparative rabies DNA vaccine effectiveness through glycoprotein gene modifications.
    Osinubi MO; Wu X; Franka R; Niezgoda M; Nok AJ; Ogunkoya AB; Rupprecht CE
    Vaccine; 2009 Nov; 27(51):7214-8. PubMed ID: 19925956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sindbis virus replicon-based DNA vaccine encoding Rabies virus glycoprotein elicits specific humoral and cellular immune response in dogs.
    Gupta PK; Dahiya SS; Kumar P; Rai A; Patel CL; Sonwane AA; Saini M
    Acta Virol; 2009; 53(2):83-8. PubMed ID: 19537908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to neonatal genetic immunization.
    Wang Y; Xiang Z; Pasquini S; Ertl HC
    Virology; 1997 Feb; 228(2):278-84. PubMed ID: 9123835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response.
    Rath A; Choudhury S; Batra D; Kapre SV; Rupprecht CE; Gupta SK
    Virus Res; 2005 Nov; 113(2):143-52. PubMed ID: 15978691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.
    Xiang ZQ; Spitalnik S; Tran M; Wunner WH; Cheng J; Ertl HC
    Virology; 1994 Feb; 199(1):132-40. PubMed ID: 8116236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
    Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
    Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene immunization of mice with plasmid DNA expressing rabies virus glycoprotein.
    Fodor I; Kucsera L; Fodor N; Pálfi V; Grabko VI
    Acta Vet Hung; 2000; 48(2):229-36. PubMed ID: 11402706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].
    Li W; Zhang Y; Wang S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):61-5. PubMed ID: 12526306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recombinant replication-defective adenovirus based rabies vaccine].
    Li WH; Zhang Y; Wang SH; Liu L; Yang F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):650-4. PubMed ID: 14714304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
    Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
    Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
    Kaur M; Saxena A; Rai A; Bhatnagar R
    FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine adenovirus based rabies vaccines.
    Tordo N; Foumier A; Jallet C; Szelechowski M; Klonjkowski B; Eloit M
    Dev Biol (Basel); 2008; 131():467-76. PubMed ID: 18634509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies.
    Borhani K; Ajorloo M; Bamdad T; Mozhgani SH; Ghaderi M; Gholami AR
    Arch Iran Med; 2015 Apr; 18(4):223-7. PubMed ID: 25841942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production, purification and analysis of an experimental DNA vaccine against rabies.
    Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
    J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabies virus glycoprotein and immune response pattern using recombinant protein or recombinant RNA viral vectors.
    Astray RM; Ventini DC; Boldorini VL; Silva FG; Rocca MP; Pereira CA
    Vaccine; 2014 May; 32(24):2829-32. PubMed ID: 24598721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses to nucleic acid vaccines to rabies virus.
    Xiang ZQ; Spitalnik SL; Cheng J; Erikson J; Wojczyk B; Ertl HC
    Virology; 1995 Jun; 209(2):569-79. PubMed ID: 7778289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.